Funding for this research was provided by:
Wellcome Trust (106534)
Received: 20 November 2018
Accepted: 31 May 2019
First Online: 10 June 2019
Ethics approval and consent to participate
: Ethical approval was obtained from the University College London Research Ethics Committee (REC) (approval number: 11371/001) on 17 July 2017. Approval was also obtained locally from Ghana Health Service Ethics Review Committee (GHS-ERC Number- 007/09/17) on 16 October 2017. Before the commencement of the FGDs, the aims of the study were explained to all the participants and they were asked to sign an informed consent form. They were also informed that their participation was voluntary and that they could withdraw from the study at any time. In addition, they were assured that all their responses would be treated confidentially.
: Not applicable.
: The author declares that he has no competing interests.